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Over half a million individuals are diagnosed with head and neck cancer each year world-
wide. Radiotherapy is an important curative treatment for this disease, but it requires man-
ually intensive delineation of radiosensitive organs at risk (OARs). This planning process
can delay treatment commencement. While auto-segmentation algorithms offer a potentially
time-saving solution, the challenges in defining, quantifying and achieving expert perfor-
mance remain. Adopting a deep learning approach, we demonstrate a 3D U-Net architecture
that achieves performance similar to experts in delineating a wide range of head and neck
OARs. The model was trained on a dataset of 663 deidentified computed tomography (CT)
scans acquired in routine clinical practice and segmented according to consensus OAR defi-
nitions. We demonstrate its generalisability through application to an independent test set of
24 CT scans available from The Cancer Imaging Archive collected at multiple international
sites previously unseen to the model, each segmented by two independent experts and con-
sisting of 21 OARs commonly segmented in clinical practice. With appropriate validation
studies and regulatory approvals, this system could improve the effectiveness of radiotherapy
pathways.
1 Introduction
Each year, 550,000 people are diagnosed with cancer of the head and neck worldwide [1]. This incidence
is rising [2], more than doubling in certain subgroups over the last 30 years [3, 4, 5]. Where available,
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2most will be treated with radiotherapy which targets the tumour mass and areas at high risk of microscopic
tumour spread. However, normal anatomical structures (‘organs at risk’, OARs) may also be irradiated,
with the dose received being directly correlated with adverse symptoms suffered [6, 7, 8]. Strategies to
reduce incidental OAR dosing can reduce the side effects incurred [9].
The efficacy and safety of head and neck radiotherapy requires accurate OAR and tumour segmenta-
tion. However, the results of this process can be both inconsistent and imperfect in accuracy [10]. It is
predominantly done manually, and so is dependent on the high-level expertise and consistent performance
of the individuals performing the task. Unsurprisingly, large inter- and intra-practitioner variability exists,
which can create challenges for the quality assurance of dosimetric impact on OARs [11]. Segmentation
is also very time consuming: an expert can spend four hours or more on a single case [12]. This can
cause clinically significant delays to treatment commencement (see Fig. 1); the duration of this delay is
associated with increased risk of both local recurrence and overall mortality [13, 14]. Notably, the rising
incidence of head and neck cancers [4] is driving demand for experts which might ultimately be hard
to meet. Indeed, increasing demands for and shortages of trained staff already place a heavy burden on
healthcare systems, which can lead to long delays for patients as radiotherapy is planned [15, 16]. Such
pressures also present a barrier to the implementation of “Adaptive Radiotherapy”, in which radiotherapy
would be adapted to anatomic changes (such as tumour shrinkage) during treatment, preventing healthy
tissue being exposed to greater radiation doses than necessary [17]. This unnecessary exposure could be
avoided if OARs could be re-segmented at sufficiently regular intervals during a course of radiotherapy.
Deep learning may signicantly 
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Figure 1 A typical clinical pathway for radiotherapy. After a patient is diagnosed and the decision is made to
treat with radiotherapy, a defined workflow aims to provide treatment that is both safe and effective; in the UK the time
delay between decision to treat and treatment delivery should be no greater than 31 days. The manual segmentation
and dose optimisation steps are manually intensive, and introduce potential delays to patients receiving treatment.
Our work aims to reduce delays in manual segmentation (highlighted below in red) by evaluating deep learning in
the first manual segmentation step (highlighted above). Note that in some centres OARs may be segmented by
oncologists instead of therapeutic radiographers.
Automated (i.e. computer-performed) segmentation has the potential to address these challenges but,
to date, performance of available solutions in clinical practice has proven inferior to that of expert human
operators. Most segmentation algorithms in clinical use are atlas-based, producing their segmentations by
extrapolating from manually labelled training examples. These algorithms might not sufficiently account
for the variability in normal anatomical structure which exists between patients, particularly when con-
sidering the effect different tumours may have on local anatomy; thus these may be prone to systematic
error. They perform at expert levels on only a small number of organs and the segmentations require
3significant editing by human experts. Thus, they have failed to significantly improve clinical workflows
[18, 19, 20, 21, 22, 23, 24, 25, 26, 27].
In recent years, deep learning based algorithms have proven capable of delivering substantially better
performance than traditional segmentation algorithms. In particular the U-Net convolutional architecture
[28] has shown promise in the area of deep-learning based medical image segmentation (see, e.g. [29]). In
head and neck cancer segmentation, several deep learning based approaches have been proposed. Some
of them use standard classification networks on patches [30, 31, 32, 33] with tailored pre- and post-
processing, while others also use U-Net based architectures [34, 35, 36].
Despite the promise deep learning offers, challenges remain in developing clinical applicable algo-
rithms. In particular the definition of ’expert’ performance for a radiotherapy use case, unbiased quan-
tification of this compared with human experts and subsequently achieving this present barriers to the
application of auto-segmentation in radiotherapy treatment planning.
Here we address these challenges with a deep learning approach that performs at a standard similar to
human experts in delineating a wide range of important OARs from radiotherapy scans for head and neck
cancer. We achieve this by using a study design that includes (i) the introduction of a clinically-meaningful
performance metric for segmentation in radiotherapy planning; (ii) a representative set of images and
an independent test set from a site previously unseen to the model; (iii) an unambiguous segmentation
protocol for all organs; and (iv) a segmentation of each test set image according to these protocols by two
independent experts. By achieving performance similar to experts on a new and previously unseen group
of patients we demonstrate the generalisability, and thus clinical applicability, of our approach.
2 Results
2.1 Datasets
We collated a representative sample of Computed Tomography (CT) scans used to plan curative-intent
radiotherapy of head and neck cancer patients at University College London Hospitals NHS Foundation
Trust (UCLH). To demonstrate the generalisability of models, we curated a test and validation set of open
source CT scans available from The Cancer Imaging Archive (“TCIA test set”) [37, 38, 39]. Table 1 details
the characteristics of these datasets and the patient demographics. Twenty-one organs at risk were selected
to represent a wide range of anatomical regions throughout the head and neck; to account for human
variability each case was segmented by a single radiographer with a second arbitrating and compared with
a ground truth from two further radiographers arbitrated by one of two independent specialist oncologists.
For more information on dataset selection, inclusion and exclusion criteria for patients and OARs please
refer to the Methods section; further details are also described in a published protocol describing the
collaboration with UCLH [40].
For the original volumetric segmentations received from UCLH, only those that meet quality and pro-
tocol conformity thresholds were included in the training data. Additional segmentations were added in
the form of per-organ labelled axial slices to expand the training set while volumetric segmentations were
added for OARs that consisted of fewer than ten slices. All training set segmentations were performed
by experienced therapeutic radiographers1 and went through a review and editing process with a second
radiographer. Please refer to the Methods section for more details.
1‘Radiographer’ is the term used to describe radiation therapy technologists in the United Kingdom and Australasia.
Dosimetrists are other staff members that may be trained in manual segmentation. Oncologists are doctors specialising
in the treatment of cancer. All oncologists involved in the reviewing and editing of manual segmentations for this study
regularly plan radiotherapy treatment for head and neck patients as part of their routine clinical work.
4Table 1 Dataset Characteristics
UCLH TCIA PDDCA
Train Validation Test Validation Test Test
Total scans (patients) 663 (389) 100 (51) 75 (46) 7 (6) 24 (24) 15 (15)
Average patient age 57.1 57.5 57.6 56.5 59.9 58.6
Gender Female 207 (115) 36 (19) 18 (12) 2 (2) 2 (2) 2 (2)
Male 450 (271) 64 (32) 57 (34) 5 (4) 20 (20) 9 (9)
Unknown 6 (3) 0 0 0 2 (2) 4 (4)
Tumour site Oropharynx 145 (86) 27 (15) 23 (11) 0 8 (8) 2 (2)
Lip, oral cavity and pharynx 80 (52) 20 (8) 7 (6) 1 (1) 3 (3) 0
Tongue 53 (26) 8 (5) 1 (1) 2 (2) 7 (7) 0
Larynx 46 (31) 8 (3) 6 (4) 2 (2) 4 (4) 0
Nasopharynx 48 (24) 5 (3) 1 (1) 0 0 0
Head, face and neck 37 (23) 8 (3) 8 (4) 0 0 0
Nasal Cavity 32 (19) 2 (1) 3 (2) 0 0 0
Connective and soft tissue 37 (18) 2 (1) 5 (2) 0 0 0
Hypopharynx 17 (10) 1 (1) 3 (2) 2 (1) 1 (1) 0
Accessory sinus 10 (7) 2 (1) 0 0 0 0
Oesophagus 6 (2) 1 (1) 1 (1) 0 0 0
Other 33 (20) 0 1 (1) 0 1 (1) 0
Unknown 119 (71) 16 (9) 16 (11) 0 0 13 (13)
Source TCGA - - - 2 (2) 7 (7) 0
HN_Cetux - - - 5 (4) 17 (17) 15 (15)
Site UCLH 663 (389) 100 (51) 75 (46) 0 0 0
MD Anderson Cancer Clinic 0 0 0 2 (2) 7 (7) 0
Unknown (US) 0 0 0 5 (4) 17 (17) 15 (15)
Tumour sites are taken from ICD codes. Numbers show number of scans as well as numbers of unique patients in parenthesis.
"TCGA": The Cancer Genome Atlas Head-Neck Squamous Cell Carcinoma[39], an open source dataset hosted on TCIA.
"HN_Cetux": Head-Neck Cetuximab, an open source dataset hosted on TCIA[37]. "PDDCA": Public Domain Database for
Computational Anatomy dataset released as part of the 2015 challenge in the segmentation of head and neck anatomy at the
International Conference On Medical Image Computing & Computer Assisted Intervention (MICCAI).
2.2 Qualitative performance
We used a 3D U-Net architecture [28, 41] with similar design choices as in a study of De Fauw and
colleagues [29] (see Fig. 7). At each resolution we use residual blocks [42] with a combination of padded
xy-convolutions and unpadded z-convolutions. The unpadded convolutions allow very efficient training
when the labelled slices are sparse within the scan and allow a seamless tiling [28, 41] of large volumes
in the z-direction which is useful because the full volumes do not fit into the memory of the Graphics
Processing Unit (GPU). In contrast to common semantic segmentation tasks our 21 segmentation labels
are not mutually exclusive, i.e. a voxel can belong to multiple structures, like "spinal cord" and "spinal
canal". In order to account for this the final layer of the network applies a (channel wise) sigmoid instead
of a softmax. Network training is done on subvolumes determined by a central slice and the required
context for that slice. To account for the class imbalance – the organ volumes range from around 65mm3
(cochlea) to around 1,400,000mm3 (brain) – we use a top-k loss [43] during training. The prediction
is done in tiles in the z-direction. The model took on average less than 30 seconds on a single GPU to
compute the 21 OAR predictions for each test set scan. For further details please refer to the Methods
section.
Qualitative examples of the model’s performance on a representative CT scan from the TCIA test set
are shown in Fig. 2. Deep learning segmentations are shown against a ground truth defined by a consultant
oncologist with over 10 years of experience in segmenting OARs. The levels shown as 2D slices have
5been selected to demonstrate all 21 OARs included in this study.
Figure 2 Example results from a randomly selected case from the TCIA test set. Five axial slices from the
scan of a 66 year old male patient with a right base of tongue cancer with bilaterial lymph node involvement selected
from the Head-Neck Cetuximab TCIA dataset (patient 0522c0057; [37]). (a1-e1) The raw CT scan slices at five
representative levels were selected to best demonstrate the OARs included in the work. The window levelling has
been adjusted for each to best display the anatomy present. (a2-e2) The ground truth segmentation was defined by
experienced radiographers and arbitrated by a head and neck specialist oncologist. (a3-e3) Segmentations produced
by our model. (a4-e4) Overlap between the model (yellow line) and the ground truth (blue line). Two further randomly
selected TCIA set scans are shown in Fig. 11 and Fig. 12. Best viewed on a display.
62.3 Quantitative performance
For quantitative analysis we introduce a segmentation performance metric, "surface Dice-Sørensen Co-
efficient" (surface DSC), that is better suited for the presented use case than the standard volumetric
Dice-Sørensen Coefficient (volumetric DSC; [44]) as it provides a measure of the agreement between just
the surfaces of two structures.
In our use case, predicted segmentations would be reviewed and potentially corrected by a human ex-
pert, so we primarily care about the fraction of the surface that needs to be redrawn because it is too
far from the ground truth surface (see Fig. 3). The volumetric DSC is not well suited for this because
it weights all misplaced segmentation labels equally and independently of their distance from the sur-
face. For example, a segmentation that violates the surface tolerance by a small amount at many places
(requiring the time-consuming correction of large parts of the border) might still get a good volumetric
DSC score. In contrast, another segmentation that violates the surface tolerance by a large degree but at a
single place (which could be manually corrected with relative ease) might end up with a poor volumetric
DSC score. Furthermore the volumetric DSC penalises the deviation from the ground truth relative to the
organ’s volume. In radiotherapy planning the absolute deviation (in mm) is important, independent of the
organ’s size, to ensure that radiation planning can be accurately and safely performed.
acceptable deviation
a b
Figure 3 Surface DSC performance metric. (a) Illustration of the computation of the surface DSC. Continuous
line: predicted surface. Dashed line: ground truth surface. Black arrow: the maximum margin of deviation which may
be tolerated without penalty, hereafter referred to by τ . Note that in our use case each OAR has an independently
calculated value for τ . Green: acceptable surface parts (distance between surfaces ≤ τ ). Pink: unacceptable
regions of the surfaces (distance between surfaces > τ ). The proposed surface DSC metric reports the good
surface parts compared to the total surface (sum of predicted surface area and ground truth surface area). (b)
Illustration of the determination of the organ-specific tolerance. Green: segmentation of an organ by oncologist A.
Black: segmentation by oncologist B. Red: distances between the surfaces. We defined the organ-specific tolerance
as the 95th percentile of the distances collected across multiple segmentations from a subset of seven TCIA scans,
where each segmentation was performed a radiographer arbitrated by an oncologist, neither of whom had seen the
scan previously.
To evaluate the surface DSC we first defined organ-specific tolerances (in mm) as a parameter of the
proposed metric. We computed these acceptable tolerances for each organ by measuring the inter-observer
variation in segmentations between three different consultant oncologists (each with over 10 years of
experience in clinical oncology delineating OARs) on a subset of our TCIA images. To penalise both
false negative and false positive parts of the predicted surface our proposed metric uses the overlapping
7area from both surfaces (the predicted surface and the ground truth surface) and normalises it by the total
surface area (sum of predicted surface area and ground truth surface area). Like the volumetric DSC, the
surface DSC ranges from 0 (no overlap) to 1 (perfect overlap). Put simply, a surface DSC of 0.95 means
that approximately 95% of the surface was properly outlined (as defined by the acceptable tolerance
parameter τ ) while 5% needs to be corrected. For a more formal definition and implementation, please
refer to the Methods section.
Model performance was evaluated alongside that of therapeutic radiographers (each with at least 4
years of experience) segmenting an independent test and validation set collected from an entirely different
population than the training dataset. Each test set case was segmented by a single radiographer with a
second arbitrating, and compared with a ground truth from two further radiographers arbitrated by one of
two independent specialist oncologists.
The models performed similarly to humans: on 19 of 21 OARs there was no substantial difference
between the deep learning models and that of the radiographers (Fig. 4 and Table 4). Given the variations
of performance differences, we define a substantial difference here as 5% or more. The two exceptions
were the brainstem and right lens, where our model’s performance was inferior to that of the human
experts.
To understand the performance in clinical practice we computed an aggregated surface DSC per patient
over only those organs that would currently be segmented given that patient’s tumour diagnosis. As dif-
ferent OARs have largely different sizes the aggregate surface DSC provides a better estimate of potential
time saved for each patient. Here we first summed up the overlapping surface area as well as the total
surface area of all relevant organs for the individual patient. We then computed the surface DSC (Table 4
last rows). We found that for all 24 patients there was no substantial difference between the models and
the radiographers performance in any individual patient (Table 4 last row).
In addition to demonstrating a surface DSC score comparable to that of the radiographers’ we also
report the standard volumetric DSC scores, despite its shortcomings for our described use case, to al-
low a qualitative comparison of our results to those in the existing literature. An accurate quantitative
comparison to previously published literature is difficult due to inherent differences in the datasets used:
performance may vary considerably across datasets and a meaningful comparison cannot be achieved
without defining, and subsequently using, a consistent and precise protocol for how OARs should be seg-
mented and obtaining results on the same dataset. For more detailed results demonstrating surface DSC
and volumetric DSC for each individual patient from the TCIA test set please refer to Table 4 and Table 5
respectively in the appendix.
2.4 Comparison to previous work
Table 2 shows the results of a systematic review of relevant previous papers reporting mean volumetric
DSC for the unedited automatic delineation of head and neck OARs from CT images. These are compared
with our model’s performance on the TCIA open source test set, as well as an additional test set from the
original UCLH dataset (“UCLH test set”) and the Public Domain Database for Computational Anatomy
(PDDCA) dataset released as part of the 2015 MICCAI challenge in the segmentation of OARs for head
and neck radiotherapy (“PDDCA test set”; [45]). To contextualise the performance of our model, radiog-
rapher performance is shown on the TCIA test set, and oncologist inter-observer variation is shown on the
UCLH test set. Each study used different data sets, scanning parameters and labelling protocols and so
the resulting volumetric DSC results vary significantly. No studies were identified that included lacrimal
glands. While not used as the primary test set we nevertheless present both surface DSC and volumetric
DSC for each individual PDDCA test set patient in Table 6 and Table 7 respectively in the appendix.
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a Surface DSC at organ-specific tolerance
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Figure 4 Quantitative performance of the model in comparison to radiographers. (a) Surface DSC (on the
TCIA open source test set) for the segmentations compared to the gold standard for each organ at an organ-specific
tolerance τ . Bars show the mean value. Blue: our model, green: radiographers. (b) Performance difference between
the model and the radiographers. Each blue dot represents a model-radiographer pair. Red lines show the mean
difference. The grey area highlights non-substantial differences (-5% to +5%)
9Table 2 Volumetric DSC performance of our model and previously published results.
Study Method Brain Brainstem Cochlea Lacrimal Lens Lung Mandible Optic Nerve Orbit Parotid Spinal-Canal Spinal-Cord Submandibular
lt rt lt rt lt rt lt rt lt rt lt rt lt rt lt rt
Hoogeman (2008) [21] Multi-ABAS 711 711
Sims (2009) [24] Multi-ABAS 77 82 84 86
Qazi (2011) [23] HAS 91 93
Teguh (2011) [25] Multi-ABAS 781 79 781 70
Daisne (2013) [18] Single-ABAS 752 722
Fortunati (2013) [19] HAS 78 67 62 81 85
Thomson (2014) [26] HAS 302,3 793 803
Hoang Duc (2015) [20] Multi-ABAS 832 592 632 622 752
Walker (2015) [27] HAS 97 56 98 71 89 90 73
Fritscher (2016) [30] Deep learning 81 65
Ibragimov (2017) [31] Deep learning 90 64 65 88 88 77 78 87 70 73
Raudashl (2017) [45] HAS 88 93 62 84 78
Hänsch (2018) [34] Deep learning 86
Mocˇnik (2018) [32] Deep learning 77
Ren (2018) [33] Deep learning 72 70
Tam (2018) [46] Machine learning 91 67 72 75 74 85 94 94 83 82 83 87 87
Wang (2018) [47] Machine learning 90 94 82 83
Zhu (2018) [35] Deep learning 87 93 72 71 88 87 81 81
Tong (2018) [36] Deep learning 87 94 65 69 84 83 76 81
Radiographer (TCIA) Manual 99.1 89.5 77.9 72.0 65.6 66.5 87.2 83.4 98.7 98.8 93.9 78.8 77.6 92.9 93.0 86.7 87.0 93.9 84.0 83.3 74.9
(24 scans) ±0.3 ±2.2 ±8.0 ±20.3 ±10.3 ±10.4 ±8.3 ±15.6 ±0.7 ±0.5 ±2.3 ±5.0 ±6.4 ±1.9 ±1.7 ±3.5 ±3.1 ±1.9 ±4.8 ±19.7 ±30.2
Our model (TCIA) Deep Learning 99.0 79.1 81.8 80.8 61.8 60.6 80.0 73.1 98.8 98.6 93.8 78.1 77.0 91.5 92.1 83.2 84.0 92.3 80.0 80.3 76.0
(24 scans) ±0.2 ±9.6 ±6.7 ±7.8 ±12.9 ±10.8 ±18.4 ±28.2 ±0.6 ±1.0 ±1.6 ±5.1 ±5.0 ±2.1 ±1.9 ±5.4 ±3.7 ±1.8 ±7.8 ±7.8 ±16.5
Oncologist (UCLH) Manual 99.05 91.95 68.5 75.8 63.3 61.6 86.2 87.6 98.45 98.65 95.45 77.1 76.0 94.85 94.85 90.15 90.75 94.95 87.75 91.15 90.15
(8 - 75 scans)4 ±14.8 ±8.5 ±13.1 ±14.3 ±10.1 ±9.9 ±6.3 ±7.1
Our model (UCLH) Deep Learning 99.15 87.65 65.2 74.9 69.1 69.6 80.6 80.0 98.75 98.85 95.75 76.0 77.2 95.15 94.85 85.35 84.95 95.05 88.15 85.45 84.85
(8 - 75 scans)4 ±15.3 ±10.0 ±11.5 ±11.7 ±11.6 ±11.6 ±5.8 ±6.1
Our model (PDDCA) Deep Learning 79.5 94.0 71.6 69.7 86.7 85.3 76.0 77.9
(15 scans) ±7.8 ±2.0 ±5.8 ±7.1 ±2.8 ±6.2 ±8.9 ±7.4
Values for volumetric DCS are mean (± standard deviation) unless otherwise stated. “ABAS”: atlas based auto segmentation.
“HAS”: hybrid atlas-based segmentation.
1 merged brainstem and spinal cord.
2 Values estimated from figures; actual values not reported.
3 Median; mean not reported.
4 Number of scans per organ varies, see Table 8.
5 Volumetric DSC estimated from sparse labels.
3 Discussion
3.1 Model performance
We demonstrate an automated deep learning-based segmentation algorithm that can perform to a sim-
ilar standard as experienced radiographers across a wide range of important OARs for head and neck
radiotherapy. The final model performance in all regions except brainstem and right lens was similar to
radiographers when compared to a gold standard of an expert consultant oncologist with over 10 years
experience in treating patients with head and neck cancer. Our system was developed using CT scans de-
rived from routine clinical practice with a test and validation set consisting of a new population collected
from several different radiotherapy planning datasets, demonstrating the generalisability of an approach
that should be applicable in a hospital setting for segmentation of OARs, routine Radiation Therapy Qual-
ity Assurance (RTQA) peer review and reducing the associated variability between different radiotherapy
centres [48].
For 19 of the 21 OARs studied, our model achieved near expert radiographer level performance on the
TCIA test set of scans taken from a previously unseen open source dataset. In brainstem and right lens
the model’s surface DSC score deviated by more than 5% from the radiographer performance, although
the volumetric DSC for lens was similar to state-of-art compared to previously published results. Several
factors may have contributed to this impaired performance. For brainstem, which comprises the midbrain,
pons and medulla oblongata, the deviation between the ground truth and model segmentations frequently
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occurred in defining where the brainstem begins. Brouwer and colleagues [49] define the level at which
the brain transitions to brainstem (midbrain) as being that which extends inferior from the lateral ventri-
cles. This definition is somewhat imprecise and thus difficult for the models to learn, and may also be
confounded by inconsistencies observed between ground truth labels in the training data. If implemented
in clinical practice, brainstem segmentation may require an oncologist or radiographer to edit, although
it is possible that a post processing step to smooth the transition level between brainstem and brain could
resolve this issue. Significant variation was observed in the lens, with the right lens falling below the
5% error margin of radiographer performance on the TCIA test set. Potential explanations may be the
difficulty of identifying its borders in routine practice on CT scans, and the 2.5mm slice thickness and
partial voluming effects due to the small size of the lens. These factors are evident on inspection of the
data: performance in the UCLH test set (where scan quality was more consistent) was within the threshold
for radiographer performance, while in a number of cases in the TCIA test set the lens was particularly
difficult to identify and the model failed to segment it entirely (Fig. 10). Clinically, lower accuracy in
outlining the lens is less concerning: during treatment a patient is unlikely to maintain the same gaze
direction as in the planning CT scan. For this reason, the generally accepted International Guidelines [49]
recommend instead delineating anterior and posterior orbit, regions that were not present in the training
dataset. Future work will address this limitation by developing models that delineate these regions instead
of the lenses.
Performance may have been affected by biases in the TCIA test set, which was made up of open source
scans from a range of different centres. In particular, the Head-Neck Cetuximab inclusion criteria selected
for patients with advanced head and neck cancer. This could have introduced a bias in favour of the
humans and against our system by providing a more difficult set of images with substantial differences
to the dataset on which the model was trained. In addition, although we excluded scans that were not
representative of those used in routine clinical practice, the overall quality varied considerably when
compared to the training and validation sets that were collected at a single specialist centre with access
to high quality CT scanners. This may help to explain poorer performance on the lens OAR, where scan
quality can make the borders difficult to ascertain (Fig. 10).
A final potential source of error is variability in training data. While all of our internally created seg-
mentation volumes were created to adhere to a defined protocol, interobserver variation may still have
confounded the results. A notable example of this is where the retromandibular vein runs through the
parotid gland. The protocol used includes the vein only when it is fully encapsulated by parotid tissue;
identifying this could be dependent on variables such as image artefacts and strength of contrast enhance-
ment. Such variation, along with differences in image quality and in the software used to create the
segmentations, is not uncommon in the ground truth and reflects the variation that might be seen in clin-
ical practice [10]. The resulting variation may limit model performance as it introduces deviations from
a consistent protocol in the training set; despite this, the model still performed to human expert standards
in the majority of OARs.
3.2 Surface DSC: a clinically applicable performance metric
In this work we introduce the surface DSC, a metric conceived to be sensitive to clinically significant
errors in delineation of organs at risk. While segmenting OARs for radiotherapy, small deviations in bor-
der placement can have a potentially serious impact, increasing the risk of debilitating side effects for the
patient. Misplacement by only a small offset may require the whole region to be redrawn and in such
cases an automated segmentation algorithm may offer no time-savings at all. The volumetric DSC is rel-
atively insensitive to such small changes for large organs as the absolute overlap is also large. Difficulties
identifying the exact borders of smaller organs, often due to ambiguity in the imaging process, can result
in large differences in volumetric DSC even if these differences are not clinically relevant in terms of their
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effect on radiotherapy treatment. By strongly penalising border placement outside a tolerance derived
from consultant oncologists, the surface DSC metric resolves these issues. Future work should investigate
the extent to which the surface DSC correlates with the saved time for manual segmentation.
3.3 Comparison with previous work
At least 11 auto-contouring software solutions are currently available commercially, with varying claims
regarding their potential to lower segmentation time during radiotherapy planning [50]. The principal
factor in determining whether or not automatic segmentations are time-saving during the radiotherapy
workflow is whether they produce segmentations which are acceptable to oncologists and whether they
require extensive (i.e. time consuming) corrections. Ibragimov and colleagues [31] used convolutional
neural networks (CNN) smoothed by a Markov Random Fields algorithm and published the most com-
prehensive analysis to date, reporting a wide variation in geometric accuracy. Although performance for
OARs such as mandible and spinal cord was good (volumetric DSC 0.90 and 0.87 respectively), per-
formance on OARs which lack easily distinguishable intensity features was notably worse than existing
non-deep learning algorithms (see Table 2 for more details on this and other prior publications). Indeed,
there is considerable variation in the volumetric DSC reported in prior work. Although not directly com-
parable due to different datasets and labelling protocols, we present volumetric DSC results that compare
favourably against the existing published literature for many of the OARs. Furthermore we present these
results on three separate test sets, two of which (the TCIA and the PDDCA test sets) use different segmen-
tation protocols. In those where the volumetric DSC score is higher in the published literature both our
model and the human radiographers achieved similar scores, suggesting that current and previous results
are particularly incomparable – either due to including more difficult cases than previous studies or due to
the differences we have mentioned above. To allow more objective comparisons of different segmentation
methods, we make our labelled TCIA datasets freely available to the academic community.2
Several studies have improved on the state-of-art results for OARs in CT scans released as part of the
2015 MICCAI Challenge in Head & Neck segmentation [45]. The challenge organisers added ground
truth segmentations to selected scans from the Head-Neck Cetuximab TCIA dataset (one of the two open
source datasets from which we selected our TCIA test set, though there was only a single scan present
in both respective test sets). Scans in the MICCAI challenge set differ from our TCIA test set both
in segmentation protocol and axial slice thickness. To further demonstrate the generalisability of our
approach we present our volumetric DSC results on this dataset also (PDDCA test set, Table 2). Despite
these differences, and without including any of their segmentations in our training data, our performance
is still comparable to state-of-art for all organs except for brainstem (see previous discussion).
3.4 Limitations
The wide variability in state-of-art and limited uptake in routine clinical practice motivates the need for
clinical studies evaluating model performance in practice. Future work will seek to define the clinical
acceptability of the segmented OARs produced by our models, and estimating the time-saving which
could be achieved during the radiotherapy planning workflow.
A number of other study limitations should also be addressed in future work. We included only planning
CT scans since magnetic resonance imaging (MRI) and Positron Emission Tomography (PET) scans were
not routinely performed for all patients in the UCLH dataset. Some OAR classes, such as optic chiasm,
require co-registration with MRI images for optimal delineation and access to additional imaging has been
shown to improve the delineation of optic nerves [32]. As a result certain OAR classes were deliberately
excluded from this CT-based project and will be addressed in future work including MRI scans. With
2The dataset is available at https://github.com/deepmind/tcia-ct-scan-dataset.
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regard to the classes of OARs in this study we present a larger set of OARs than previously reported
[18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 45, 30, 31, 34, 33, 46, 47, 35] but there are some omissions (e.g.,
oral cavity) as there were not a sufficient number of examples in the training data that conformed to a
standard international protocol. The number of oncologists used in the creation of our ground truth may
not have fully captured the variability in OAR segmentation, or may have been biased towards a particular
interpretation of the Brouwer Atlas used as our segmentation protocol. Even in an organ as simple as the
spinal cord that is traditionally done well by autosegmentation algorithms there is ambiguity between
the inclusion of, for example, the nerve roots. Such variation may widen the thresholds of acceptable
deviation in favour of the model despite a consistent protocol. Future work will address these deficits,
alongside lymph node regions which represent another time consuming aspect of OAR outlining during
radiotherapy planning.
3.5 Conclusion
In conclusion, we demonstrate that deep learning can achieve near human performance in the segmen-
tation of a head and neck OARs on radiotherapy planning CT scans using a clinically applicable perfor-
mance metric designed for this clinical scenario. We provide evidence of the generalisability of this model
by testing it on patients from entirely different demographics. This segmentation algorithm can be used
with very little loss in accuracy compared to an expert and has the potential to improve the speed and
efficiency of radiotherapy workflows, therefore positively influencing patient outcomes. Future work will
investigate the impact of our segmentation algorithm in clinical practice.
4 Methods
4.1 Datasets
University College London Hospitals NHS Foundation Trust (UCLH) serves an urban, mixed socioeco-
nomic and ethnicity population in central London, U.K. and houses a specialist centre for cancer treat-
ment. Data were selected from a retrospective cohort of all adult (>18 years of age) UCLH patients who
had computed tomography (CT) scans to plan radical radiotherapy treatment for head and neck cancer
between 01/01/2008 and 20/03/2016. Both initial CT images and re-scans were included. Patients with
all tumour types, stages and histological grades were considered for inclusion, so long as their CT scans
were available in digital form and of sufficient diagnostic quality. The standard CT element size was
0.976mm by 0.976mm by 2.5mm, and scans with non-standard spacing (with the exception of 1.25mm
spacing scans which were subsampled) were excluded to ensure consistent performance metrics during
training (note that for the TCIA test set, below, neither element height nor width were exclusion criteria
and each ranged from 0.94mm - 1.27mm and were always equal to form square pixels in the axial plane.
For the PDDCA test set we included all scans, and the voxels varied between 2mm and 3mm in height
and ranged similarly in the axial dimension from 0.98mm - 1.27mm). The wishes of patients who had
requested that their data should not be shared for research were respected.
Of the 513 patients who underwent radiotherapy at UCLH within the given study dates a total of 486
patients (838 scans), mean age 57, male 337, female 146, gender unknown 3, met the inclusion criteria.
Of note, no scans were excluded on the basis of poor diagnostic quality. Scans from UCLH were split into
a training set (389 patients, 663 scans), validation set (51 patients, 100 scans) and test set (46 patients,
75 scans). No patient was included in multiple datasets: in cases where multiple scans were present
for a single patient, all were included in the same subset. Where multiple scans were present for a single
patient this reflects planning CT scans taken for the purpose of re-planning radiotherapy due to anatomical
changes during a course of treatment. While it is important for models to perform well in both scenarios
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Patients treated at UCLH within study dates
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sharing
Yes | 509 patients
No | 4 patients
TCIA: HN_C
111
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46 (75 scans)
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24 (24 scans)
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No | 15 patients
ExcludedCompliant scan resolution
Yes | 97 patients
No | 150 patients
Figure 5 Case selection from UCLH and TCIA CT datasets. A consort-style diagram demonstrating the appli-
cation of inclusion and exclusion criteria to select the training, validation (val) and test sets used in this work.
as post operative OAR anatomy can differ from definite radiotherapy anatomy in important ways, to avoid
potential correlation between the same organs segmented twice in the same dataset care was taken to avoid
this in the TCIA test set (see below).
In order to assess the generalisability of the dataset, a separate validation and test set was curated from
CT planning scans selected from two open source datasets available from The Cancer Imaging Archive
[38]: TCGA-HNSC [39] and Head-Neck Cetuximab [37]. Non-CT planning scans and those that did not
meet the same slice thickness as the UCLH scans (2.5mm) were excluded. These were then manually
segmented in-house according to the Brouwer Atlas ([49]; the segmentation procedure is described in
further detail below). We included 31 scans (22 Head-Neck Cetuximab, 9 TCGA-HNSC) which met
these criteria, which we further split into validation (6 patients, 7 scans) and test (24 patients, 24 scans)
sets (Fig. 5). The original segmentations from the Head-Neck Cetuximab dataset were not included; a
consensus assessment by experienced radiographers and oncologists found the segmentations either non-
conformant to the selected segmentation protocol or below the quality that which would be acceptable
for clinical care. The original inclusion criteria for Head-Neck Cetuximab were patients with stage III-IV
carcinoma of the oropharynx, larynx, and hypopharynx, having Zubrod performance of 0-1, and meeting
predefined blood chemistry criteria between 11/2005 to 03/2009. The TCGA-HNSC dataset included
patients treated for Head-Neck Squamous Cell Carcinoma, with no further restrictions being apparent.
For more information please refer to the specific citations [39, 37].
All test sets were kept separate during model training and selection, and only accessed for the final
assessment of model performance, while the validation set was used only for model selection (see the
Methods section for more details). Table 1 describes in further detail the demographics and characteristics
within the datasets; to obtain a balanced demographic in each of the test, validation and training datasets
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we sampled randomly stratified splits and selected one that minimised the differences between the key
demographics in each dataset.
In addition the PDDCA open source dataset consisted of 15 patients selected from the Head-Neck
Cetuximab open source dataset [37]; due to differences in selection criteria and test/validation/training
set allocation there was only a single scan present in both the TCIA and PDDCA test sets. This dataset
was used without further post-processing and only accessed once for assessing the volumetric DCS per-
formance. For more details on the dataset characteristics and preprocessing please refer to the work of
Raudaschl and colleagues [45].
4.2 Clinical taxonomy
In order to select which OARs to include in the study, we used the Brouwer Atlas (consensus guide-
lines for delineating OARs for head and neck radiotherapy, defined by an international panel of radiation
oncologists; [49]). From this, we excluded those regions which required additional magnetic resonance
imaging for segmentation, were not relevant to routine head and neck radiotherapy, or that were not used
clinically at UCLH. This resulted in a set of 21 organs at risk; see Table 3.
4.3 Clinical labelling & annotation
Due to the large variability of segmentation protocols used and annotation quality in the UCLH dataset,
all segmentations from all scans selected for inclusion in the training set were manually reviewed by a
radiographer with at least 4 years experience in the segmentation of head and neck OARs. Volumes that
did not conform to the Brouwer Atlas were excluded from training. In order to increase the number of
training examples, additional axial slices were randomly selected for further manual OAR segmentations
to be added based on model performance or perceived imbalances in the dataset. These were then pro-
duced by a radiographer with at least 4 years experience in head and neck radiotherapy, arbitrated by a
second radiographer with the same level of experience. The total number of examples from the original
UCLH segmentations and the additional slices added are provided in Table 3.
For the TCIA test and validation sets, the original dense segmentations were not used due to poor
adherence to the chosen study protocol. To produce the ground truth labels the full volumes of all 21
OARs included in the study were segmented. This was done initially by a radiographer with at least four
years experience in the segmentation of head and neck OARs and then arbitrated by a second radiographer
with similar experience. Further arbitration was then performed by a radiation oncologist with at least
five years post-certification experience in head and neck radiotherapy. The same process was repeated
with two additional radiographers working independently but after peer arbitration these segmentations
were not reviewed by an oncologist; rather they became the human reference to which the model was
compared. This is shown schematically in Fig. 6. Prior to participation all radiographers and oncologists
were required to study the Brouwer Atlas for head and neck OAR segmentation [49] and demonstrate
competence in adhering to these guidelines.
4.4 Model architecture
We used a residual 3D U-Net architecture with 8 levels (see Fig. 7). Our network takes in a CT volume
(single channel) and outputs a segmentation mask with 21 channels, where each channel contains the
binary segmentation mask for a specific OAR. Due to the unpadded convolutions in the z-direction, the
output volume has 20 slices less than the input volume. The network consists of 7 residual convolutional
blocks in the downward path, a residual fully connected block at the bottom, and 7 residual convolutional
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Table 3 Taxonomy of segmentation regions.
OAR Total number of labelled
slices included
Anatomical Landmarks and Definition
Brain 5847 Sits inside the cranium and includes all brain vessels excluding
the brainstem and optic chiasm.
Brainstem 8559 The posterior aspect of the brain including the midbrain, pons and
medulla oblongata. Extending inferior from the lateral ventricles
to the tip of the dens at C2. It is structurally continuous with the
spinal cord.
Cochlea-Lt 1786 Embedded in the temporal bone and lateral to the internal
auditory meatus.Cochlea-Rt 1819
Lacrimal-Lt 13038 Concave shaped gland located at the superolateral aspect of the
orbit.Lacrimal-Rt 12976
Lens-Lt 5341 An oval structure that sits within the anterior segment of the
orbit. Can be variable in position but never sitting posterior
beyond the level of the outer canthus.
Lens-Rt 5407
Lung-Lt 4690 Encompassed by the thoracic cavity adjacent to the lateral aspect
of the mediastinum, extending from the 1st rib to the diaphragm
excluding the carina.
Lung-Rt 4990
Mandible 9722 The entire mandible bone including the temporomandibular joint,
ramus and body, excluding the teeth. The mandible joins to the
inferior aspect of the temporal bone and forms the entire lower
jaw.
Optic-Nerve-Lt 2111 A 2-5mm thick nerve that runs from the posterior aspect of the
eye, through the optic canal and ends at the lateral aspect of the
optic chiasm.
Optic-Nerve-Rt 1931
Orbit-Lt 4117 Spherical organ sitting within the orbital cavity. Includes the
vitreous humor, retina, cornea and lens with the optic nerve
attached posteriorly.
Orbit-Rt 3900
Parotid-Lt 5182 Multi lobed salivary gland wrapped around the mandibular
ramus. Extends medially to styloid process and parapharyngeal
space. Laterally extending to subcutaneous fat. Posteriorly
extending to sternocleidomastoid muscle. Anterior extending to
posterior border of mandible bone and masseter muscle. In
cases where retromandibular vein is encapsulated by parotid
this is included in the segmentation.
Parotid-Rt 6646
Spinal-Canal 23100 Hollow cavity that runs through the foramen of the vertebrae, ex-
tending from the base of skull to the end of the sacrum.
Spinal-Cord 22460 Sits inside the Spinal Canal and extends from the level of the
foramen magnum to the bottom of L2.
Submandibular-Lt 4313 Sits within the submandibular portion of the anterior triangle of
the neck, making up the floor of the mouth and extending both
superior and inferior to the posterior aspect of the mandible and
is limited laterally by the mandible and medially by the
hypoglossal muscle.
Submandibular-Rt 4473
blocks in the upward path. A 1x1x1 convolution layer with sigmoidal activation produces the final output
in the original resolution of the input image.
We trained our network with a regularised top-k-percent pixel-wise binary cross-entropy loss [43]: for
each output channel, we selected the top 5% most difficult pixels (those with the highest binary cross-
entropy) and only added their contribution to the total loss. This speeds up training and helps the network
to tackle the large class imbalance and to focus on difficult examples.
We regularised the model using standard L2 weight regularisation with scale 10−6 and extensive data
augmentation: we used random in-plane (i.e. in x- and y- directions only) translation, rotation, scaling,
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Radiographer B
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Figure 6 Process for segmentation of ground truth and radiographer OAR volumes. The flowchart illustrates
how the ground truth segmentations were created and compared with independent radiographer segmentations and
the model. For the ground truth each CT scan in the TCIA test set was segmented first by a radiographer and peer
reviewed by a second radiographer. This then went through one or more iterations of review and editing with a
specialist oncologist before creating a ground truth used to compare with the segmentations produced by both the
model and additional radiographers.
shearing, mirroring, elastic deformations, and pixel-wise noise. We used uniform translations between
-32 and 32 pixels; uniform rotations between -9 and 9 degrees; uniform scaling factors between 0.8 and
1.2; and uniform shear factors between -0.1 and 0.1. We mirrored images (and adjusted corresponding
left and right labels) with a probability of 0.5. We performed elastic deformations by placing random
displacement vectors (standard deviation: 5mm, in-plane displacements only) on a control point grid with
100mm x 100mm x 100mm spacing and by deriving the dense deformation field using cubic b-spline
interpolation. In the implementation all spatial transformations are first combined to a dense deformation
field, which is then applied to the image using bilinear interpolation and extrapolation with zero padding.
We added zero mean Gaussian intensity noise independently to each pixel with a standard deviation of 20
Hounsfield Units.
We trained the model with the Adam optimiser [51] for 120,000 steps and a batch size of 32 (32 GPUs)
using synchronous SGD. We used an initial learning rate of 10−4 and scaled the learning rate by 1/2, 1/8,
1/64, and 1/256 at timesteps 24,000, 60,000, 108,000, and 114,000, respectively.
We used the validation set to select the model which performed at over 95% for the most OARs ac-
cording to our chosen surface DSC performance metric, breaking ties by preferring better performance on
more clinically impactful OARs and the absolute performance obtained.
4.5 Performance metrics
All performance metrics are reported for each organ independently (e.g., separately for just the left
Parotid), so we only need to deal with binary masks (e.g. a left partotid voxel and a non left-parotid
voxel). Masks are defined as a subset of R3, i.e.M⊂ R3 (see Fig. 8).
17
fc_block
sigmoid
m
n
c 
ReLU
m 
n c
m
c 
m 
c
Input shape
down
(3, 0, 32)
down
(3, 0, 32)
down
(3, 0, 64)
down
(1, 2, 64)
down
(1, 2, 128)
down
(1, 2, 128)
down
(0, 4, 256, 
False)
up
(3, 64)
up
(3, 64)
up
(3, 64)
up
(3, 64)
up
(4, 128)
up
(4, 128)
up
(4, 256,
False)
Feature map 
shapes
Output shapea
b
Figure 7 3D U-Net model architecture. (a) At training time, the model receives 21 contiguous CT slices, which
are processed through a series of “down” blocks, a fully connected block, and a series of “up” blocks to create a
segmentation prediction. (b) A detailed view of the convolutional residual up and down blocks, and the residual fully
connected block.
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Figure 8 Illustrations of masks, surfaces, border regions, and the “overlapping” surface at tolerance τ
The volume of a mask is denoted as |·|, with∣∣M∣∣ = ˆ
M
dx .
With this notation the standard (volumetric) DSC for two given masksM1 andM2 can be written as
CDSC =
2
∣∣M1 ∩M2∣∣∣∣M1∣∣+ ∣∣M2∣∣ .
In the case of sparse ground truth segmentations (i.e. only a few slices of the CT scan are labelled), we
estimate the volumetric DSC by aggregating data from labelled voxels across multiple scans as
CDSC, est =
2
∑
p
∣∣∣M1,p ∩M2,p ∩ Lp∣∣∣∑
p
∣∣∣M1,p ∩ Lp∣∣∣+ ∣∣∣M2,p ∩ Lp∣∣∣ ,
where the mask M1,p and the labelled region Lp represent the sparse ground truth segmentation for a
patient p and the maskM2,p is the full volume predicted segmentation for patient p.
Due to the shortcomings of the volumetric DSC metric for the presented radiotherapy use case, we
introduce the “surface DSC” metric, which assesses the overlap of two surfaces (at a specified tolerance)
instead of the overlap of two volumes (see Results section). A surface is the border of a mask, S = ∂M,
the area of a surface is denoted as ∣∣S∣∣ = ˆ
S
dσ
where σ ∈ S is a point on the surface, using an arbitrary parameterisation. The mapping from this
parameterisation to a point in R3 is denoted as ξ : S → R3, i.e. x = ξ(σ). With this we can define the
border region B(τ)i ⊂ R3, for the surface Si, at a given tolerance τ as
B(τ)i =
{
x ∈ R3 | ∃σ ∈ Si, ‖x− ξ(σ)‖ ≤ τ
}
,
(see Fig. 8 for an example). Using these definitions we can write the “surface DSC at tolerance τ” as
R
(τ)
i,j =
∣∣∣∣Si ∩ B(τ)j ∣∣∣∣+ ∣∣∣∣Sj ∩ B(τ)i ∣∣∣∣∣∣Si∣∣+ ∣∣∣Sj∣∣∣ ,
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using an informal notation for the intersection of the surface with the boundary, i.e.:∣∣∣∣Si ∩ B(τ)j ∣∣∣∣ := ˆ
Si
1B(τ)j
(
ξ(σ)
)
dσ
4.6 Implementation
The computation of surface integrals on sampled images is not straightforward, especially for medical
images, where the voxel spacing is usually not equal in all three dimensions. The common approximation
of the integral by counting surface voxels can lead to substantial systematic errors.
Another common challenge is the representation of the surface with voxels. As the surface of a binary
mask is located between voxels, a definition of “surface voxels” in the raster-space of the image introduces
a bias: using foreground voxels to represent the surface leads to an underestimation of the surface, while
the use of background voxels leads to an overestimation.
Our proposed implementation uses a surface representation that provides less biased estimates but still
allows us to compute the performance metrics with linear complexity (O(N), withN : number of voxels).
We place the surface points between the voxels on a raster that is shifted by half of the raster spacing on
each axis (see Fig. 9 for a 2D illustration). For 3D images, each point in this raster has 8 neighbouring
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Figure 9 2D illustration of the implementation of the surface DSC. (a) A binary mask displayed as image. The
origin of the image raster is (0,0). (b) The surface points (red circles) are located in a raster that is shifted half of
the raster spacing on each axis. Each surface point has 4 neighbours in 2D (8 neighbours in 3D). The local contour
(blue line) assigned to each surface point (red circle) depends on the neighbour constellation.
voxels. As we analyse binary masks, there are only 28 = 256 possible neighbour constellations. For
each of these constellations we compute the resulting triangles using the marching cube triangulation
[52] and store the surface area of the triangles (in mm2) in a look-up table. With this look-up table we
then create a surface image (on the above mentioned raster) that contains zeros at positions that have 8
identical neighbours or the local surface area at all positions that have both foreground and background
neighbours. These surface images are created for the masks M1 and M2. Additionally we create a
distance map from each of these surface images using the distance transform algorithm [53]. Iterating
over the non-zero elements in the first surface image and looking up the distance from the other surface in
the corresponding distance map allows to create a list of tuples (surface element area, distance from other
surface). From this list we can easily compute the surface area by summing up the area of the surface
elements that are within the tolerance. To account for the quantised distances – there is only a discrete
set D =
{√
(n1d1)2 + (n2d2)2 + (n3d3)2 | n1, n2, n3 ∈ N
}
of distances between voxels in a 3D raster
with spacing (d1, d2, d3) – we also round the tolerance to the nearest neighbour in the setD for each image
before computing the surface DSC. For more details, please have a look at our open source implementation
of the surface DSC, available from https://github.com/deepmind/surface-distance.
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5 Code availability
The codebase for the deep learning framework makes use of proprietary components and we are un-
able to publicly release this code. However, all experiments and implementation details are described in
sufficient detail in the methods section to allow independent replication with non-proprietary libraries.
The surface DSC performance metric code is available at https://github.com/deepmind/
surface-distance.
6 Data availability
The clinical data used for training and validation sets were collected at University College London Hospi-
tals NHS Foundation Trust and transferred to the DeepMind data centre in the UK in de-identified format.
Data were used with both local and national permissions. They are not publicly available and restrictions
apply to their use. The data, or a subset, may be available from UCLH NHS Foundation Trust subject to
local and national ethical approvals. The released test/validation set data was collected from two datasets
hosted on The Cancer Imaging Archive (TCIA). The subset used, along with the ground truth segmenta-
tions added is available at https://github.com/deepmind/tcia-ct-scan-dataset.
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Table 4 Surface DSC on TCIA data set
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mean, stddev diff.
Brain
(M) 93.7 94.2 96.3 94.5 93.7 92.7 93.3 98.3 93.5 92.9 97.1 94.6 95.1 97.3 94.2 94.5 96.9 97.2 97.0 94.6 96.1 96.1 95.4 94.4 95.1±1.5
(84056.5 mm2)
(H) 96.9 95.8 96.5 94.7 93.4 96.5 96.0 96.8 94.7 96.0 98.0 95.8 96.9 98.2 96.1 97.3 96.7 97.6 95.7 96.5 97.2 95.6 95.3 95.3 96.2±1.1 -1.1
Brainstem
(M) 80.3 67.1 93.0 76.9 59.9 72.0 66.3 98.7 84.0 65.4 97.6 76.5 96.4 94.4 62.9 56.4 96.0 98.7 95.4 92.9 90.7 90.7 86.9 93.7 83.0±13.7
(6580.3 mm2)
(H) 96.3 96.9 88.5 95.9 93.0 99.2 94.0 97.3 97.3 92.6 99.6 95.9 97.4 99.6 96.6 97.1 98.5 98.0 97.8 97.5 99.0 98.0 97.8 97.7 96.7±2.5 -13.7
Cochlea-Lt
(M) 95.0 100.0 97.3 96.8 100.0 100.0 100.0 99.7 97.5 92.7 95.8 100.0 100.0 100.0 100.0 95.0 100.0 100.0 100.0 100.0 98.3 100.0 97.9 100.0 98.6±2.1
(89.6 mm2)
(H) 100.0 100.0 89.7 93.5 94.3 90.5 100.0 90.0 100.0 94.5 100.0 99.2 94.3 100.0 98.7 100.0 92.2 92.8 91.0 100.0 100.0 99.6 91.6 100.0 96.3±4.0 2.2
Cochlea-Rt
(M) 100.0 98.7 99.0 92.5 100.0 100.0 98.7 99.2 94.7 94.2 97.0 93.5 100.0 99.6 100.0 100.0 100.0 100.0 87.9 100.0 93.8 100.0 98.7 100.0 97.8±3.2
(84.1 mm2)
(H) 100.0 100.0 0.0 100.0 95.1 88.0 90.1 100.0 100.0 94.1 100.0 100.0 100.0 100.0 98.4 95.5 82.7 93.3 77.1 94.7 100.0 100.0 100.0 98.8 92.0±20.1 5.8
Lacrimal-Lt
(M) (95.8) (92.2) (96.5) (88.5) (73.4) (84.7) (94.0) (95.4) (81.9) (76.3) (97.1) (81.9) (93.5) (96.2) (85.6) (96.3) (96.2) (97.8) (98.4) (99.6) (97.2) (99.3) (96.1) (98.6) 92.2±7.4
(527.9 mm2)
(H) (99.9) (90.6) (84.8) (98.4) (88.3) (99.6) (91.5) (90.5) (85.7) (99.9) (99.9) (95.3) (99.9) (95.2) (90.8) (87.7) (92.8) (92.6) (89.0) (96.2) (98.4) (93.5) (94.9) (97.7) 93.9±4.7 -1.7
Lacrimal-Rt
(M) (95.7) (96.2) (98.3) (83.8) (82.6) (86.3) (86.3) (86.5) (96.0) (69.9) (91.4) (89.0) (91.7) (96.9) (88.1) (97.8) (88.4) (96.1) (99.2) (97.2) (89.2) (96.9) (92.1) (94.8) 91.3±6.6
(555.3 mm2)
(H) (99.7) (98.2) (96.1) (97.7) (91.4) (95.1) (84.3) (81.7) (96.6) (99.0) (100.0) (88.4) (96.5) (96.0) (94.3) (93.9) (89.1) (98.7) (93.4) (91.9) (93.0) (81.9) (92.9) (82.5) 93.0±5.5 -1.7
Lens-Lt
(M) 100.0 95.7 92.0 99.7 99.9 100.0 86.9 91.9 98.1 100.0 100.0 0.0 99.9 99.5 92.4 96.9 96.6 98.6 97.6 99.9 99.8 96.0 96.2 100.0 93.2±19.7
(190.8 mm2)
(H) 100.0 96.1 100.0 95.0 99.9 100.0 100.0 100.0 95.6 99.9 100.0 88.5 100.0 99.9 95.9 97.4 94.7 100.0 97.6 99.9 99.4 96.5 100.0 99.4 98.2±2.7 -4.9
Lens-Rt
(M) 99.2 0.0 92.1 99.6 100.0 96.0 95.3 0.0 95.5 95.4 100.0 0.0 93.1 95.9 98.9 96.3 99.8 92.0 95.8 100.0 99.9 99.4 91.8 95.7 84.7±32.1
(189.9 mm2)
(H) 100.0 74.1 96.9 99.9 100.0 96.2 95.7 81.0 99.4 100.0 100.0 85.1 99.8 96.1 100.0 97.5 100.0 92.8 96.0 99.7 100.0 99.2 100.0 100.0 96.2±6.6 -11.6
Lung-Lt
(M) (99.4) (98.7) (93.9) (98.9) (96.9) (98.6) (87.8) (96.8) (98.1) (98.4) (99.0) (97.1) (95.1) (99.2) (99.4) (98.0) (98.6) (99.6) (99.0) (98.6) (99.4) (99.6) (99.0) (98.4) 97.8±2.5
(59476.5 mm2)
(H) (98.8) (99.3) (99.8) (97.1) (97.1) (96.0) (96.9) (95.2) (99.1) (98.5) (100.0) (97.5) (97.5) (99.1) (99.7) (97.5) (98.2) (99.0) (99.4) (98.8) (99.2) (96.4) (99.9) (90.7) 97.9±2.0 -0.1
Lung-Rt
(M) (99.2) (98.7) (80.3) (98.6) (98.1) (98.7) (90.7) (93.9) (98.2) (98.7) (98.3) (96.2) (92.2) (98.7) (99.1) (95.3) (99.2) (98.7) (99.2) (98.4) (98.5) (99.5) (99.5) (97.0) 96.9±4.1
(61894.6 mm2)
(H) (98.7) (99.4) (99.8) (96.7) (97.8) (98.7) (97.1) (95.2) (98.2) (98.4) (100.0) (97.9) (97.0) (99.3) (99.3) (94.9) (99.0) (99.2) (99.2) (98.1) (98.4) (97.0) (99.8) (96.1) 98.1±1.4 -1.3
Mandible
(M) 96.9 96.1 97.3 94.0 96.7 98.4 93.4 97.3 97.1 96.3 99.9 94.0 98.9 97.4 93.0 94.2 98.2 98.4 97.4 99.0 99.0 95.3 95.8 98.6 96.8±1.9
(20870.5 mm2)
(H) 99.0 99.9 96.1 97.3 99.5 94.3 97.7 99.5 95.8 99.3 100.0 99.4 99.8 98.9 99.5 93.6 92.4 98.5 96.7 98.1 98.8 99.2 99.4 98.3 98.0±2.1 -1.2
Optic-Nerve-Lt
(M) 95.4 98.9 98.5 99.7 95.5 93.4 97.8 93.2 90.5 99.4 99.2 100.0 94.8 99.3 98.8 99.9 97.7 99.6 100.0 98.9 99.9 98.9 98.4 94.5 97.6±2.6
(712.6 mm2)
(H) 88.9 99.3 99.8 99.2 91.5 98.6 99.3 94.9 85.7 90.3 98.3 98.7 95.9 96.4 91.1 100.0 99.9 100.0 100.0 91.7 94.7 96.3 98.4 95.4 96.0±4.0 1.6
Optic-Nerve-Rt
(M) 92.7 98.6 98.7 99.8 98.7 96.3 98.1 99.1 99.8 99.9 97.1 93.5 89.7 99.7 100.0 99.3 94.9 93.8 96.3 97.2 99.7 100.0 99.7 90.8 97.2±3.0
(701.7 mm2)
(H) 88.0 99.3 95.1 96.8 94.6 99.7 98.5 98.7 95.2 99.8 99.3 99.5 94.5 98.5 96.6 100.0 99.5 99.7 95.0 93.2 96.2 95.3 97.7 96.2 97.0±2.8 0.3
Orbit-Lt
(M) 94.7 95.8 91.4 94.6 94.6 88.6 91.9 94.6 95.7 98.6 98.5 94.3 98.1 91.7 93.3 83.1 97.9 92.6 87.6 90.3 94.7 91.9 90.4 97.8 93.4±3.7
(2307.9 mm2)
(H) 97.3 98.2 95.2 92.4 93.7 92.8 95.2 96.4 98.2 95.5 98.0 98.6 98.3 97.2 97.9 89.8 99.7 93.6 89.2 88.9 99.4 96.1 93.5 96.0 95.5±3.1 -2.0
Orbit-Rt
(M) 96.8 97.4 92.5 96.9 97.2 91.7 92.7 91.2 98.6 99.3 96.6 94.7 95.9 93.0 95.7 85.3 99.3 92.0 93.1 96.4 90.4 90.9 96.8 93.0 94.5±3.3
(2355.7 mm2)
(H) 99.5 93.9 92.5 95.5 98.1 95.3 97.6 97.1 95.2 97.4 96.1 92.7 99.9 94.7 95.4 90.9 95.6 92.9 96.7 89.1 99.1 91.0 96.0 90.9 95.1±2.9 -0.7
Parotid-Lt
(M) 91.6 79.4 90.2 93.8 91.2 94.4 68.4 95.6 75.6 88.9 92.8 91.1 95.4 97.5 84.5 87.2 94.3 92.3 92.8 92.4 84.8 74.6 94.8 97.9 89.2±7.5
(7978.0 mm2)
(H) 93.7 81.8 92.7 93.7 96.0 98.0 87.8 91.3 99.0 96.0 97.9 92.8 97.1 97.4 99.0 89.2 90.3 92.7 97.0 93.6 97.2 89.5 96.6 97.2 94.1±4.1 -4.8
Parotid-Rt
(M) 95.2 81.8 88.0 93.4 95.8 83.3 91.3 91.6 72.9 91.5 97.1 91.9 93.3 96.1 86.2 92.3 88.7 91.6 94.2 93.7 73.2 94.0 90.4 93.9 90.1±6.3
(8307.5 mm2)
(H) 96.1 89.9 90.5 89.3 97.5 94.7 92.6 97.7 92.5 94.8 99.4 98.7 92.8 96.8 94.2 95.2 94.8 93.7 97.1 92.2 92.5 97.2 89.7 94.6 94.4±2.8 -4.3
Spinal-Canal
(M) (96.2) (92.1) (97.9) (93.0) (92.0) (90.8) (87.9) (95.3) (87.5) (88.8) (96.5) (92.8) (90.0) (91.6) (86.6) (97.6) (88.2) (94.4) (91.9) (93.6) (98.2) (94.8) (92.4) (92.3) 92.6±3.3
(18278.6 mm2)
(H) (95.2) (96.2) (95.7) (91.1) (94.4) (92.3) (95.7) (94.7) (96.0) (97.1) (99.4) (94.0) (94.7) (94.8) (96.6) (97.8) (92.7) (97.2) (95.3) (92.9) (92.9) (94.2) (95.7) (91.9) 94.9±1.9 -2.3
Spinal-Cord
(M) 99.9 99.1 99.2 99.4 100.0 99.8 99.6 99.6 94.4 97.5 100.0 98.8 97.9 98.6 98.8 100.0 100.0 99.7 100.0 99.2 99.8 100.0 98.4 99.6 99.1±1.2
(8679.2 mm2)
(H) 99.1 99.7 99.8 100.0 99.2 99.9 99.9 100.0 99.8 99.9 100.0 99.0 98.7 99.4 100.0 100.0 100.0 100.0 100.0 99.9 99.9 100.0 99.9 100.0 99.8±0.4 -0.6
Submandibular-Lt
(M) (81.1) (74.9) (84.6) (85.1) (98.6) (94.7) (66.9) (92.5) (97.5) (80.4) (90.9) (81.2) (86.6) (94.0) (66.1) (89.7) (85.2) (-) 90.9 (64.4) (-) (-) (85.3) (79.3) 84.3±9.6
(3160.6 mm2)
(H) (90.5) (97.9) (97.5) (94.4) (97.7) (97.3) (77.0) (98.2) (97.7) (96.2) (100.0) (90.0) (96.5) (96.8) (94.4) (99.8) (68.8) (-) 97.3 (0.0) (-) (-) (90.6) (90.9) 89.0±21.2 -4.7
Submandibular-Rt
(M) (76.5) (90.3) (65.5) (75.7) (88.7) (94.8) (82.9) (91.4) (90.7) (88.1) (92.5) (88.2) (91.4) (92.0) (77.3) (77.6) (95.1) (34.0) (43.5) (68.8) (-) (80.8) (-) (63.6) 79.5±15.9
(3169.9 mm2)
(H) (83.4) (99.3) (91.5) (84.4) (91.7) (97.8) (89.3) (96.0) (91.3) (99.6) (100.0) (89.7) (91.6) (96.0) (98.7) (97.0) (87.0) (0.0) (0.0) (76.6) (-) (86.1) (-) (0.0) 79.4±32.1 0.1
(M) 94.0 92.3 95.5 94.1 93.4 92.5 91.2 97.5 91.3 92.7 97.5 93.7 95.8 97.1 92.2 92.7 96.5 96.9 96.6 95.2 94.1 94.6 94.9 95.4aggr. surface DSC1
(H) 97.1 95.9 95.6 95.1 95.2 96.5 95.9 97.1 95.4 96.6 98.5 96.6 97.3 98.3 96.8 96.2 95.8 97.2 96.3 96.2 97.4 96.1 96.1 96.1
difference -3.0 -3.5 -0.1 -1.1 -1.8 -4.0 -4.7 0.3 -4.1 -3.8 -1.1 -2.9 -1.4 -1.2 -4.7 -3.5 0.7 -0.4 0.3 -1.0 -3.4 -1.5 -1.3 -0.7
Numbers below the organ name show the average surface area of this organ in the test set.
M: our model performance
H: human (radiographer) performance
numbers in brackets indicate that this organ for this patient would not be segmented in current clinical practise
1: aggregated only over organs that would be segmented for this patient in current clinical practise. I.e. numbers in brackets were excluded.
Colours indicate the performance difference:
< -10% (model is worse)
-10% to -5% (model is slightly worse)
-5% – +5% (model and human are on par)
+5% to +10% (model is slightly better)
> +10% (model is better)
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Table 5 Volumetric DSC on TCIA data set
TCIA test set patient ID
Organ M/H 05
22
c
00
17
05
22
c
00
57
05
22
c
01
61
05
22
c
02
26
05
22
c
02
48
05
22
c
02
51
05
22
c
03
31
05
22
c
04
16
05
22
c
04
19
05
22
c
04
27
05
22
c
04
57
05
22
c
04
79
05
22
c
06
29
05
22
c
07
68
05
22
c
07
70
05
22
c
07
73
05
22
c
08
45
TC
G
A
-C
V-
72
36
TC
G
A
-C
V-
72
43
TC
G
A
-C
V-
72
45
TC
G
A
-C
V-
A
6J
O
TC
G
A
-C
V-
A
6J
Y
TC
G
A
-C
V-
A
6K
0
TC
G
A
-C
V-
A
6K
1
mean, stddev diff.
Brain
(M) 98.9 98.8 99.2 98.7 98.8 98.2 98.8 99.2 98.8 98.8 99.1 98.9 99.1 99.2 98.8 98.8 99.0 99.3 99.3 98.9 99.2 99.2 99.0 99.0 99.0±0.2
(1382857.1 mm3)
(H) 99.2 99.1 99.3 98.7 98.7 98.9 98.9 98.7 98.8 99.2 99.8 99.1 99.3 99.3 99.1 99.1 98.9 99.3 99.1 99.1 99.3 98.6 98.9 99.0 99.1±0.3 -0.1
Brainstem
(M) 78.0 69.2 82.9 73.2 67.6 70.1 71.4 90.8 78.1 63.6 91.2 69.6 89.1 88.9 66.0 59.3 86.9 87.4 87.1 85.5 82.6 86.3 86.0 87.9 79.1±9.6
(27219.8 mm3)
(H) 90.4 90.4 86.9 86.0 86.2 92.3 87.0 89.2 88.9 86.8 94.9 87.0 91.1 92.8 88.9 91.9 91.3 89.4 90.2 88.5 91.3 87.5 89.4 88.9 89.5±2.2 -10.4
Cochlea-Lt
(M) 71.2 81.0 79.2 90.6 79.1 89.6 81.8 82.4 81.0 74.1 80.0 87.3 87.0 81.2 85.2 76.0 91.9 88.9 76.2 86.3 70.9 94.7 70.8 76.5 81.8±6.7
(66.2 mm3)
(H) 79.1 74.4 75.7 81.6 73.9 70.2 71.4 68.8 89.5 72.3 100.0 75.8 75.9 90.9 76.9 81.8 70.0 78.8 62.7 88.0 79.5 80.6 72.4 80.4 77.9±8.0 3.8
Cochlea-Rt
(M) 83.0 85.7 90.3 83.6 86.4 89.6 77.6 82.8 71.7 77.3 68.8 80.0 82.5 83.9 83.3 86.8 78.8 81.0 55.9 89.8 71.6 90.9 80.0 77.8 80.8±7.8
(63.9 mm3)
(H) 71.4 92.3 0.0 81.8 61.8 60.4 51.3 86.7 97.4 76.2 100.0 83.7 72.5 88.0 73.7 61.9 55.0 66.7 51.7 72.7 93.3 72.7 84.2 72.5 72.0±20.3 8.8
Lacrimal-Lt
(M) 62.0 60.8 75.9 56.4 37.6 51.8 48.9 69.3 51.9 37.8 72.4 36.7 68.3 66.5 44.4 68.8 66.2 70.8 71.1 80.4 73.9 77.6 68.5 66.3 61.8±12.9
(585.6 mm3)
(H) 83.4 53.0 52.2 67.9 57.6 79.7 48.3 63.2 60.2 74.7 89.2 55.8 70.7 62.1 63.4 50.2 74.0 66.7 66.3 58.3 75.7 66.8 70.1 65.3 65.6±10.3 -3.8
Lacrimal-Rt
(M) 56.8 60.8 79.9 48.2 44.2 54.4 44.8 51.0 64.5 37.0 62.7 50.4 62.7 68.1 55.2 69.8 62.0 69.0 80.6 65.3 58.8 72.7 64.9 70.4 60.6±10.8
(629.8 mm3)
(H) 78.6 68.3 69.3 66.4 54.8 76.1 52.0 62.2 65.0 77.0 98.5 54.6 74.8 63.0 59.0 66.5 67.6 79.4 60.5 58.0 69.8 52.8 65.1 56.8 66.5±10.4 -5.9
Lens-Lt
(M) 85.5 77.7 73.8 87.3 87.0 91.4 79.6 60.0 82.6 86.2 83.5 0.0 91.3 86.0 65.0 90.9 79.4 91.3 82.6 87.9 88.1 87.5 86.2 89.4 80.0±18.4
(193.9 mm3)
(H) 89.8 81.0 95.6 88.7 94.1 90.9 89.9 88.2 84.1 80.3 100.0 54.1 93.0 86.0 86.5 87.4 80.0 93.9 86.8 88.2 90.1 87.4 89.3 88.1 87.2±8.3 -7.2
Lens-Rt
(M) 82.2 0.0 66.7 81.7 86.7 85.5 81.1 0.0 84.7 83.3 87.0 0.0 78.4 82.2 76.9 81.6 91.4 76.6 84.4 92.1 91.8 88.6 80.4 90.5 73.1±28.2
(194.3 mm3)
(H) 90.5 44.2 87.3 89.0 96.2 90.1 83.2 45.9 85.1 91.9 100.0 41.5 90.2 83.2 92.0 90.1 81.7 84.1 83.0 86.7 96.1 84.4 90.9 93.1 83.4±15.6 -10.3
Lung-Lt
(M) 99.2 98.9 98.4 99.3 98.7 98.8 97.0 98.6 99.0 99.1 98.5 99.1 97.0 99.1 99.3 98.7 98.4 99.2 99.1 99.3 98.9 99.3 98.7 99.1 98.8±0.6
(699853.3 mm3)
(H) 99.1 99.2 99.1 98.2 98.5 98.0 98.2 97.5 99.1 99.1 100.0 99.0 97.8 98.8 99.0 98.1 98.4 99.1 99.3 99.2 99.0 98.0 99.4 96.9 98.7±0.7 0.1
Lung-Rt
(M) 99.3 98.9 94.9 99.2 98.9 99.1 97.8 98.2 98.7 99.2 98.6 98.9 96.7 99.2 99.4 98.5 98.5 99.1 99.2 99.3 98.8 99.3 98.8 98.6 98.6±1.0
(781938.8 mm3)
(H) 99.0 99.2 99.3 98.3 98.8 98.9 98.7 98.0 99.1 99.2 100.0 99.0 98.0 98.7 98.9 98.0 98.7 99.2 99.3 99.1 98.9 98.1 99.1 98.1 98.8±0.5 -0.2
Mandible
(M) 92.2 94.0 93.8 91.3 95.0 95.4 91.1 92.3 95.4 94.4 96.4 92.4 93.8 91.0 93.2 91.9 94.8 94.6 92.3 95.5 96.5 93.3 95.4 95.4 93.8±1.6
(58458.4 mm3)
(H) 95.6 97.1 92.6 94.1 94.3 90.1 91.6 94.6 92.5 94.7 100.0 95.6 94.2 92.0 95.1 90.0 90.4 95.5 95.4 91.6 93.9 95.3 94.2 93.6 93.9±2.3 -0.1
Optic-Nerve-Lt
(M) 68.3 73.5 79.5 77.9 81.9 70.7 71.4 70.9 75.2 78.6 75.6 80.6 83.2 74.8 71.1 84.1 80.7 78.0 81.0 85.4 85.5 82.2 84.6 78.7 78.1±5.1
(744.0 mm3)
(H) 67.0 80.4 75.8 79.7 74.2 88.9 80.3 75.2 76.7 70.9 82.6 82.6 80.6 79.2 69.5 82.7 83.3 82.7 81.2 77.8 81.2 83.8 81.4 73.3 78.8±5.0 -0.7
Optic-Nerve-Rt
(M) 70.4 75.3 76.6 78.6 77.8 75.2 72.8 73.1 84.3 79.6 81.4 77.7 71.7 76.7 79.2 81.8 78.0 80.6 77.4 73.0 77.4 82.4 85.9 61.4 77.0±5.0
(715.2 mm3)
(H) 73.0 81.7 76.7 73.9 68.8 81.7 75.0 69.4 76.7 76.9 97.0 81.2 75.9 73.3 66.7 78.3 87.0 80.6 69.7 76.0 80.3 80.9 84.2 77.7 77.6±6.4 -0.6
Orbit-Lt
(M) 90.1 92.1 91.1 91.2 92.7 89.4 92.3 90.5 92.6 93.8 94.3 93.4 94.5 88.1 91.7 84.4 93.2 92.1 90.4 90.6 92.6 91.4 90.9 93.1 91.5±2.1
(8408.1 mm3)
(H) 92.7 93.7 93.2 91.0 91.7 93.0 91.7 93.1 93.2 94.1 96.2 95.2 92.0 92.6 94.6 87.0 94.7 92.3 92.0 89.9 94.9 94.7 91.6 93.7 92.9±1.9 -1.3
Orbit-Rt
(M) 92.7 93.6 91.1 93.6 94.4 90.4 92.1 90.1 94.2 94.5 92.9 93.5 93.4 90.0 92.2 86.3 94.1 91.4 93.0 91.0 90.0 91.1 93.4 92.2 92.1±1.9
(8630.3 mm3)
(H) 95.2 92.2 91.2 93.3 94.0 93.0 93.3 94.4 93.4 95.5 95.3 91.1 94.9 91.8 94.0 88.3 93.2 92.2 93.7 90.1 94.1 92.9 92.8 91.7 93.0±1.7 -0.8
Parotid-Lt
(M) 81.0 78.6 81.2 86.4 80.8 86.4 66.8 87.6 72.2 85.8 86.3 83.2 85.8 87.2 83.8 82.1 87.2 82.8 88.9 86.5 82.2 75.3 89.7 89.0 83.2±5.4
(30036.5 mm3)
(H) 82.9 79.5 83.0 86.3 85.7 90.0 83.8 85.1 89.6 90.0 95.5 83.4 87.5 87.7 91.2 84.6 85.5 83.8 89.7 86.6 89.3 83.0 89.9 88.3 86.7±3.5 -3.5
Parotid-Rt
(M) 84.4 80.2 83.6 88.6 87.0 79.6 82.1 86.4 72.6 86.4 91.4 84.2 85.4 86.7 82.9 85.9 82.6 84.2 84.6 84.4 77.5 84.7 86.2 85.1 84.0±3.7
(31394.0 mm3)
(H) 84.3 85.0 86.1 84.8 88.5 87.5 83.0 90.2 85.2 89.1 98.3 87.8 82.3 87.6 89.2 88.4 87.3 84.6 88.5 83.8 87.6 86.1 85.4 86.1 87.0±3.1 -2.9
Spinal-Canal
(M) 94.6 91.5 95.3 93.4 92.6 92.3 91.2 93.2 89.2 89.8 92.7 93.2 91.6 91.2 89.0 95.2 89.9 93.2 93.0 90.9 96.0 92.8 91.4 92.8 92.3±1.8
(64045.2 mm3)
(H) 93.0 95.5 93.8 92.3 94.1 93.4 95.1 89.9 93.7 94.6 99.5 94.4 93.0 94.1 95.0 94.3 92.3 95.9 95.5 90.9 93.7 92.0 95.3 92.3 93.9±1.9 -1.6
Spinal-Cord
(M) 76.6 84.4 66.0 86.2 86.5 82.4 85.1 84.5 56.3 78.1 89.9 76.7 86.3 79.8 81.8 88.6 86.9 68.0 81.0 70.1 78.7 83.6 83.8 79.1 80.0±7.8
(18946.8 mm3)
(H) 81.0 86.2 75.3 85.2 86.9 84.8 85.0 83.4 70.0 83.2 92.2 82.8 84.7 80.1 86.9 89.9 88.2 79.4 85.3 77.9 85.1 87.9 87.2 87.8 84.0±4.8 -4.0
Submandibular-Lt
(M) 71.1 75.8 74.0 82.3 91.7 86.3 65.1 86.7 91.8 78.8 88.2 79.7 82.0 87.9 66.3 86.5 80.4 – 85.8 69.6 – – 81.9 73.5 80.3±7.8
(9084.9 mm3)
(H) 81.5 90.7 88.5 85.8 90.7 88.6 73.7 89.7 92.6 91.0 99.8 83.0 90.1 91.5 88.1 94.3 69.8 – 90.1 0.0 – – 85.3 84.8 83.3±19.7 -3.1
Submandibular-Rt
(M) 73.7 82.6 60.7 75.5 84.4 86.2 81.4 85.8 89.9 86.2 89.2 84.8 86.3 86.3 76.8 80.8 87.7 22.0 39.8 76.1 – 76.5 – 59.7 76.0±16.5
(9177.9 mm3)
(H) 78.4 90.7 85.5 78.0 86.4 91.1 86.5 89.3 89.1 92.8 99.8 82.7 87.0 89.3 90.9 91.3 82.0 0.0 0.0 78.0 – 79.4 – 0.0 74.9±30.2 1.1
Numbers below the organ name show the average volume of this organ in the test set.
M: our model performance
H: human (radiographer) performance
Colors indicate performance differences: green: model is better, red: model is worse
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Table 6 Surface DSC on PDDCA data set
PDDCA test set patient ID
off-site test set on-site test set
Organ 05
22
c
05
55
05
22
c
05
76
05
22
c
05
98
05
22
c
06
59
05
22
c
06
61
05
22
c
06
67
05
22
c
06
69
05
22
c
07
08
05
22
c
07
27
c
05
22
c
07
46
05
22
c
07
88
05
22
c
08
06
05
22
c
08
45
05
22
c
08
57
05
22
c
08
78
mean, stddev
Brainstem 77.6 71.9 85.0 94.1 92.7 77.2 97.7 96.9 87.0 62.1 93.1 85.3 85.5 92.6 48.9 83.2±13.3
(5860.8 mm2)
Mandible 97.1 99.0 97.9 98.1 96.3 99.5 98.1 99.8 97.3 96.9 96.6 97.9 97.8 89.0 96.2 97.2±2.4
(19944.4 mm2)
Optic-Nerve-Lt 96.7 94.1 96.0 88.2 86.9 93.1 97.4 85.9 91.1 85.5 99.7 81.5 98.3 98.7 90.5 92.3±5.5
(619.1 mm2)
Optic-Nerve-Rt 95.5 97.6 97.9 91.7 84.7 89.4 95.4 93.3 97.8 75.9 99.9 79.1 95.0 98.8 89.7 92.1±7.0
(561.9 mm2)
Parotid-Lt 94.3 93.0 97.8 92.1 96.9 94.2 96.0 98.9 88.7 88.7 97.7 90.3 96.0 96.7 95.9 94.5±3.2
(7802.2 mm2)
Parotid-Rt 88.8 95.9 98.6 92.1 98.0 96.1 96.3 94.5 92.4 64.6 98.7 86.7 94.7 96.1 80.0 91.6±8.7
(7712.2 mm2)
Submandibular-Lt 67.1 67.0 90.3 78.4 81.9 67.4 87.9 81.0 95.8 68.1 98.5 75.9 72.1 98.5 79.8 80.7±11.0
(2632.6 mm2)
Submandibular-Rt 74.3 72.4 94.0 83.3 81.7 92.1 86.9 82.5 98.4 57.7 98.5 77.4 78.0 77.7 79.2 82.3±10.4
(2665.0 mm2)
aggr. surface dice 90.7 89.9 95.7 93.5 94.1 92.3 96.4 95.9 93.8 80.4 96.9 90.5 92.9 92.1 85.9
Numbers below the organ name show the average surface area of this organ in the PDDCA test set.
Table 7 Volumetric DSC on PDDCA data set
PDDCA test set patient ID
off-site test set on-site test set
Organ 05
22
c
05
55
05
22
c
05
76
05
22
c
05
98
05
22
c
06
59
05
22
c
06
61
05
22
c
06
67
05
22
c
06
69
05
22
c
07
08
05
22
c
07
27
c
05
22
c
07
46
05
22
c
07
88
05
22
c
08
06
05
22
c
08
45
05
22
c
08
57
05
22
c
08
78
mean, stddev
Brainstem 79.2 73.3 83.0 84.8 85.1 77.4 87.9 89.8 77.0 68.2 82.3 73.5 85.8 85.6 60.0 79.5±7.8
(25037.2 mm3)
Mandible 94.7 92.9 96.0 95.8 90.5 95.7 95.6 96.5 95.5 94.8 93.1 93.1 92.9 89.7 93.1 94.0±2.0
(56364.2 mm3)
Optic-Nerve-Lt 70.6 78.2 70.8 69.8 63.7 72.1 79.6 66.4 67.7 64.4 75.0 62.5 74.8 81.0 77.9 71.6±5.8
(568.3 mm3)
Optic-Nerve-Rt 70.8 74.8 77.3 63.3 61.0 62.7 64.2 72.3 79.6 60.4 77.0 61.1 66.2 80.8 73.3 69.7±7.1
(482.2 mm3)
Parotid-Lt 86.2 86.3 89.9 81.3 90.4 89.0 88.1 89.2 83.2 81.9 88.4 83.5 88.4 88.6 86.1 86.7±2.8
(30356.3 mm3)
Parotid-Rt 84.4 88.7 91.3 83.6 90.1 89.8 86.1 87.2 85.8 64.9 89.2 83.2 86.9 88.3 79.9 85.3±6.2
(30396.0 mm3)
Submandibular-Lt 67.8 62.8 82.9 74.2 79.7 67.0 78.9 78.5 86.1 64.5 90.4 73.0 65.1 90.4 78.4 76.0±8.9
(7091.3 mm3)
Submandibular-Rt 77.1 73.4 84.0 76.1 76.3 86.1 82.7 76.8 88.7 60.4 90.4 77.8 75.9 71.6 70.6 77.9±7.4
(7195.0 mm3)
Numbers below the organ name show the average volume of this organ in the PDDCA test set.
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Table 8 Number of labelled scans in UCLH test set
Brain Brainstem Cochlea Lacrimal Lens Lung Mandible Optic Nerve Orbit Parotid Spinal-Canal Spinal-Cord Submandibular
lt rt lt rt lt rt lt rt lt rt lt rt lt rt lt rt
Number of scans 75 45 8 8 75 73 75 73 71 72 74 17 15 19 16 33 32 23 24 64 65
Dense segmentation X X X X X X X X
Number of labelled slices axial 309 225 265 275 300 95 75 165 160 345 350 250 260
coronal 374 225 355 360 375 95 80 165 160 0 0 320 325
sagittal 374 225 355 360 375 95 80 165 160 0 0 320 325
Figure 10 Missed lens predictions across the TCIA test set. Consecutive axial slices of eyes showing both
a typical lens and the four cases where the model predictions omitted the lens. The window level is at a constant
W:140 L:0. (a1-a12) 12 slices through a single eye in which the model was able to detect the lens, which is clearly
visible in (a3-a6). (a1) is the upper most slice, (a12) the lower most. (b1-e12) Similar to the first row, but these four
cases are those for which the model was unable to differentiate the lens from the rest of the eye. Note that all four
cases are considerably more challenging than for the first row.
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Figure 11 Example results from a second randomly selected case from the TCIA test set. Five axial slices
from the scan of a 58 year old male patient with a cancer of the right tonsil selected from the Head-Neck Cetuximab
TCIA dataset (patient 0522c0416; [37]). (a1-e1) The raw CT scan slices at five representative levels were selected
to best demonstrate the OARs included in the work. The window levelling has been adjusted for each to best
display the anatomy present. (a2-e2) The ground truth segmentation was defined by experienced radiographers
and arbitrated by a head and neck specialist oncologist. (a3-e3) The model produced segmentations of the same
structures. Overlap between the model (yellow line) and the ground truth (blue line) is shown in (a4-e4). Best viewed
on a display.
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Figure 12 Example results from a third randomly selected case from the TCIA test set. Five axial slices from
the scan of a 53 year old female patient with a left oropharyngeal cancer with base of tongue invasion included
selected from the Head-Neck Cetuximab TCIA dataset (patient 0522c0251; [37]). (a1-e1) The raw CT scan slices
at five representative levels were selected to best demonstrate the OARs included in the work. The window levelling
has been adjusted for each to best display the anatomy present. (a2-e2) The ground truth segmentation was defined
by experienced radiographers and arbitrated by a head and neck specialist oncologist. (a3-e3) The model produced
segmentations of the same structures. Overlap between the model (yellow line) and the ground truth (blue line) is
shown in (a4-e4). Best viewed on a display.
